179 research outputs found
Message from general co-chairs and program co-chairs
published_or_final_versionThe 4th International Joint Conference on Computational Sciences and Optimization (CSO 2011)
Kunming and Lijiang, Yunnan Province, China, April 15-19, 2011. In Proceedings of the Computational Sciences and Optimization, 2011, p. 28-30
Message from general co-chairs and program co-chairs
On the cover - Computational Sciences And Optimization: Theoretical Development And Engineering Practicepublished_or_final_versionThe 3rd International Joint Conference On Computational Sciences And Optimization (Cso 2010), Huangshan, Anhui, China , 28-31 May 2010. In Computational Sciences And Optimization: Theoretical Development And Engineering Practice, 2010, v. 1, p. 15-1
The adhesion GPCR Adgrd1 is a prion protein receptor and a mediator of prion cytotoxicity
In prion diseases, the cellular prion protein PrPis converted into aggregates of PrP, leading to profound neurotoxicity through largely unknown mechanisms. Here we report that the cellular prion protein PrPacts as an antagonist of the adhesion G protein-coupled receptor (GPCR) Adgrd1. When overexpressed in cultured cells, Adgrd1 recruited the G-protein Gαs, inducing excessive cytosolic cAMP, growth arrest and cytotoxicity, all of which were suppressed by FT, a 26-meric peptide from the N-terminal flexible tail (FT) of PrP. We found that FTforms a complex with Adgrd1 and suppresses its intrinsic activation by the Stachel peptide. Adgrd1 ablation attenuated the neurodegeneration of prion-infected cerebellar organotypic slice cultures and prolonged the healthspan of prion-infected mice. Interaction studies with mutated proteins, computational modeling and docking studies revealed that suppression of Adgrd1 signaling requires the polybasic domain of the FT and the N-terminal fragment of Adgrd1. In the absence of PrP, the cAMP spike caused by Adgrd1 was suppressed by co-expression of a functionally dead Adgrd1-Adgrg6 chimeric receptor, suggesting that Adgrd1 activation requires an unidentified agonistic ligand displaced by FT. These results identify Adgrd1 as a mediator of prion toxicity and suggest that Adgrd1 modulators may be beneficial against prion-related neurodegeneration
Double Unit Umbilical Cord Blood Transplant for Adults with Acute Leukemia and Myelodysplastic Syndrome Results in Comparable Outcome As Matched Sibling or Unrelated Donor Transplant Only after Myeloablative Conditioning but Not Reduced Intensity Conditio
Triphasic Computed Tomography Enterography with Polyethylene Glycol to Detect Renal Cell Carcinoma Metastases to the Small Bowel
Enteroclysis was first used to diagnose small bowel obstruction in 1996. However, nasojejunal intubation required during enteroclysis causes discomfort to the patient. Triphasic computed tomography (CT) enterography, a noninvasive procedure that does not require intubation, was found to be an efficient method to diagnose small bowel lesions. We describe our experience of using triphasic CT enterography with polyethylene glycol (PEG) for diagnosing renal cell carcinoma (RCC) metastases to the small intestine. RCC can metastasize to many organs and can cause variable clinical presentations. We report the case of a 56-year-old man with RCC who had psoas muscle involvement and lung metastasis. The patient presented with melena and intermittent abdominal pain. Two conventional CT and small bowel series examinations had shown no obstructive lesion in the small intestine. However, triphasic CT enterography with PEG detected two enhanced masses suggestive of small bowel metastasis. The patient underwent laparotomy and segmental resection of the jejunum with primary anastomosis. Histologic examination was compatible with RCC. This is the first report where RCC metastasis to the small bowel was diagnosed using triphasic CT enterography. Our study emphasizes the importance of triphasic CT enterography in cases of obscure gastrointestinal bleeding, especially in patients suspected of having small bowel metastasis
A case–control study on the association between bladder cancer and prior bladder calculus
Exonic DNA Sequencing of ERBB4 in Bipolar Disorder
The Neuregulin-ErbB4 pathway plays a crucial role in brain development and
constitutes one of the most biologically plausible signaling pathways implicated
in schizophrenia and, to a lesser extent, in bipolar disorder (BP). However,
recent genome-wide association analyses have not provided evidence for common
variation in NRG1 or ERBB4 influencing
schizophrenia or bipolar disorder susceptibility. In this study, we investigate
the role of rare coding variants in ERBB4 in BP cases with
mood-incongruent psychotic features, a form of BP with arguably the greatest
phenotypic overlap with schizophrenia. We performed Sanger sequencing of all 28
exons in ERBB4, as well as part of the promoter and part of the
3′UTR sequence, hypothesizing that rare deleterious variants would be
found in 188 cases with mood-incongruent psychosis from the GAIN BP study. We
found 42 variants, of which 16 were novel, although none were non-synonymous or
clearly deleterious. One of the novel variants, present in 11.2% of
cases, is located next to an alternative stop codon, which is associated with a
shortened transcript of ERBB4 that is not translated. We
genotyped this variant in the GAIN BP case-control samples and found a
marginally significant association with mood-incongruent psychotic BP compared
with controls (additive model: OR = 1.64,
P-value = 0.055; dominant model:
OR = 1.73.
P-value = 0.039). In
conclusion, we found no rare variants of clear deleterious effect, but did
uncover a modestly associated novel variant that could affect alternative
splicing of ERBB4. However, the modest sample size in this
study cannot definitively rule out a role for rare variants in bipolar disorder
and studies with larger sample sizes are needed to confirm the observed
association
Foxm1 transcription factor is required for lung fibrosis and epithelial-to-mesenchymal transition
Bone mass in schizophrenia and normal populations across different decades of life
<p>Abstract</p> <p>Background</p> <p>Chronic schizophrenic patients have been reported as having higher osteoporosis prevalence. Survey the bone mass among schizophrenic patients and compare with that of the local community population and reported data of the same country to figure out the distribution of bone mass among schizophrenic patients.</p> <p>Methods</p> <p>965 schizophrenic patients aged 20 years and over in Yuli Veterans Hospital and 405 members aged 20 and over of the community living in the same town as the institute received bone mass examination by a heel qualitative ultrasound (QUS) device. Bone mass distribution was stratified to analyzed and compared with community population.</p> <p>Results</p> <p>Schizophrenic patients have lower bone mass while they are young. But aging effect on bone mass cannot be seen. Accelerated bone mass loss during menopausal transition was not observed in the female schizophrenic patients as in the subjects of the community female population.</p> <p>Conclusion</p> <p>Schizophrenic patients have lower bone mass than community population since they are young. Further study to investigate the pathophysiological process is necessary to delay or avoid the lower bone mass in schizophrenia patients.</p
- …